• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylmethylamines

Professional Introduction to Benzyl-(2-methylbenzyl)amine Hydrochloride (CAS No. 76122-58-2)

Benzyl-(2-methylbenzyl)amine hydrochloride is a chemical compound that has garnered significant attention in the field of pharmaceutical research and development due to its unique structural properties and potential biological activities. With a CAS number of 76122-58-2, this compound is of particular interest to scientists exploring novel therapeutic agents. This introduction aims to provide a comprehensive overview of its chemical characteristics, pharmacological significance, and recent advancements in its application.

The molecular structure of Benzyl-(2-methylbenzyl)amine hydrochloride consists of a benzyl group attached to a secondary amine, which is further substituted with another benzyl group. This particular arrangement contributes to its complex interactions with biological targets, making it a promising candidate for various pharmacological studies. The hydrochloride salt form enhances its solubility in aqueous solutions, facilitating its use in both in vitro and in vivo experimental settings.

In recent years, there has been growing interest in the potential applications of Benzyl-(2-methylbenzyl)amine hydrochloride in the treatment of neurological disorders. Studies have suggested that this compound may exhibit neuroprotective properties, making it a valuable candidate for further investigation. Research has indicated that it can interact with specific neurotransmitter receptors, potentially modulating pathways involved in conditions such as Alzheimer's disease and Parkinson's disease. These findings have opened new avenues for therapeutic development in the realm of neurology.

Furthermore, the compound has shown promise in the field of oncology. Preliminary studies have demonstrated that Benzyl-(2-methylbenzyl)amine hydrochloride can inhibit the growth of certain cancer cell lines by interfering with key signaling pathways involved in cell proliferation and survival. The ability to modulate these pathways makes it an attractive candidate for the development of novel anticancer agents. Additionally, its structural similarity to known bioactive molecules suggests that it may have synergistic effects when combined with other therapeutic agents.

The synthesis and characterization of Benzyl-(2-methylbenzyl)amine hydrochloride have been subjects of extensive research. Advanced synthetic methodologies have been employed to optimize its production, ensuring high purity and yield. Techniques such as catalytic hydrogenation and nucleophilic substitution have been particularly useful in achieving the desired product. Analytical methods such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry have been employed to confirm the structural integrity of the compound.

The pharmacokinetic properties of Benzyl-(2-methylbenzyl)amine hydrochloride are also areas of active investigation. Understanding how the compound is absorbed, distributed, metabolized, and excreted (ADME) is crucial for determining its efficacy and safety profile. Studies have begun to explore its bioavailability and metabolic pathways, providing insights into how it interacts with the body over time. This information is vital for designing effective dosing regimens and minimizing potential side effects.

In conclusion, Benzyl-(2-methylbenzyl)amine hydrochloride (CAS No. 76122-58-2) represents a significant area of interest in pharmaceutical research due to its unique chemical structure and potential biological activities. Its applications in treating neurological disorders and cancer have been explored, with promising results suggesting its therapeutic potential. Continued research into its synthesis, pharmacological effects, and pharmacokinetic properties will further enhance our understanding of this compound and its potential role in future medical treatments.

• 127169-00-0((2-Benzylisoindolin-4-yl)methanamine)
• 165741-71-9([(3,4-dimethylphenyl)methyl](methyl)amine)
• 39180-83-1((3,4-dimethylphenyl)methyl(ethyl)amine)
• 30922-25-9(ISOINDOLINE)
• 84227-68-9({2-(diethylamino)methylphenyl}methanamine)
• 496-12-8(2,3-dihydro-1H-isoindole)
• 93282-20-3(5-Methylisoindoline)
• 874-33-9(N-methyl-1-(2-methylphenyl)methanamine)
• 739365-30-1(4-methyl-2,3-dihydro-1H-isoindole)
• 766502-85-6((2,4-dimethylphenyl)methyl(methyl)amine)